Introducing Navigator365

Now is the time to start reimagining the future of customer engagement.

We’re excited to announce that Precision Value & Health recently acquired Across Health, a global omnichannel engagement leader.

One of their widely acclaimed assets is the feature-rich, cloud-based Navigator365 customer engagement analytics platform. This industry-leading, unique body of actionable data is your “license to operate” in an omnichannel world – from unique insights to brand/campaign planning, strategy execution, and measurable business impact.

The Navigator365 platform is used by over 50 life science companies in over 40 countries and 25+ therapeutic areas and covers 4 key dimensions:

  1. A comprehensive & dynamic view of 50+ offline & online channels
  2. Fresh insights into post-COVID content & service preferences
  3. A granular view of the media landscape
  4. A detailed competitor benchmark

To schedule a demo of Navigator365, please contact Michael Chambers, Vice President, Sales Agency and Training Teams.


“Every day we are working towards changing the standard of care for both patients and HCPs. Not everyone can say they help to change lives in their job, and I am proud to say we do!”

Beginning May 20, 2024, the Precision Value & Health family of brands is becoming Precision AQ.

Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life changing medicines. Our global offerings include:
  • Commercialization research, strategy and product planning
  • HEOR
  • Market access
  • Advertising, Branding & PR
  • Medical communications
  • Investor relations and external communications
  • Learning & development
  • Data and product solutions (Access Genius, Navigator365, OncoGenius, EHR Solutions, KOL/DOL Map)
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights. To find out more about our global services and our unified mission, to empower access to life-changing medicines for all, visit: Precision AQ

Accelerating clinical research and development through the combined power of trials, labs, and data science.

Demonstrating the value of life-science innovations with evidence and real-world expertise.